Morita, Akimichi
Okubo, Yukari
Morisaki, Yoji
Torisu-Itakura, Hitoe
Umezawa, Yoshinori
Clinical trials referenced in this document:
Documents that mention this clinical trial
Ixekizumab 80 mg Every 2 Weeks Treatment Beyond Week 12 for Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis
https://doi.org/10.1007/s13555-021-00666-x
Funding for this research was provided by:
Eli Lilly Japan
Article History
Received: 29 September 2021
Accepted: 10 December 2021
First Online: 29 December 2021